GLAX Health Press Releases

• Published on September 26, 2022 - 07:16 GMT

  

  Rakesh K. Srivastava (PhD, MBA) - Discovery of TCF-LEF Inhibitors for Diabetes, Obesity, Lung Diseases, and Cancer

  GLAX Health Announces the Discovery of TCF-LEF Inhibitors for Diabetes, Obesity, Lung Diseases, and Cancer. - Dr. Rakesh Srivastava HOUSTON, UNITED STATES, September 26, 2022 /⁨EINPresswire.com⁩/ -- Rakesh K. Srivastava (PhD, MBA) - GLAX Health Announces …

  Distribution channels: Business & Economy, Education ...
• Published on September 18, 2022 - 07:54 GMT

  

  GLAX Health Announces the Discovery of Notch Inhibitors for Cancer Therapy. Dr. Rakesh K. Srivastava

  Discovery of Notch Inhibitors for Cancer Therapy DOVER, DELAWARE, UNITED STATES, September 18, 2022 /⁨EINPresswire.com⁩/ -- GLAX Health Announces the Discovery of Notch Inhibitors for Cancer Therapy. Dr. Rakesh K. Srivastava What is Notch Signaling …

  Distribution channels: Business & Economy, Companies ...
• Published on August 27, 2022 - 16:11 GMT

  

  Dr. Rakesh Srivastava – GLAX Health announces the discovery of a new class of Nanog inhibitor for cancer therapy.

  GLAX Health announces the discovery of a new class of Nanog inhibitor for cancer therapy- Dr. Rakesh Srivastava HOUSTON, TX, USA, August 27, 2022 /⁨EINPresswire.com⁩/ -- Dr. Rakesh Srivastava – GLAX Health announces the discovery of a new class of Nanog …

  Distribution channels: Business & Economy, Education ...
• Published on August 14, 2022 - 08:23 GMT

  

  Dr. Rakesh Srivastava – Metabolism and Human Diseases

  Views of Dr. Rakesh Srivastava on Metabolism and Human Diseases WILMINGTON, DELAWARE, UNITED STATES, August 14, 2022 /⁨EINPresswire.com⁩/ -- Dr. Rakesh Srivastava – Metabolism and Human Diseases Metabolism is a complex process that regulates several …

  Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
• Published on July 1, 2022 - 08:03 GMT

  

  New Drug for New Target – Dr. Rakesh Srivastava

  New Drug for New Target – Dr. Rakesh Srivastava WILMINGTON, DELAWARE, UNITED STATES, July 1, 2022 /⁨EINPresswire.com⁩/ -- GLAX LLC, a biotechnology company, is developing targeted therapies for cancer, diabetes, and neurodegenerative disorders. The main …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on June 23, 2022 - 17:08 GMT

  

  GLAX LLC Announces Issuance of U.S. Patent for Tumor Targeted Therapy for Cancer - Dr. Rakesh K. Srivastava

  WILMINGTON, DE, USA, June 23, 2022 /⁨EINPresswire.com⁩/ -- GLAX LLC Announces Issuance of U.S. Patent for Tumor Targeted Therapy for Cancer - Dr. Rakesh K. Srivastava GLAX LLC, a biotechnology company developing targeted therapies for cancer and …

  Distribution channels: Business & Economy, Conferences & Trade Fairs ...
• Published on June 22, 2022 - 19:38 GMT

  

  GLAX LLC Obtained Patents to Treat Human Diseases – Dr. Rakesh K. Srivastava

  GLAX LLC Obtained Patents to Treat Human Diseases – Dr. Rakesh K. Srivastava NEW ORLEANS, LA, USA, June 22, 2022 /⁨EINPresswire.com⁩/ -- GLAX LLC Obtained Patents to Treat Human Diseases – Dr. Rakesh K. Srivastava GLAX LLC is dedicated in developing …

  Distribution channels: Banking, Finance & Investment Industry, Education ...
• Published on May 26, 2022 - 21:50 GMT

  

  Dr. Rakesh Srivastava – Discovery of A New Drug for The Treatment of Alzheimer’s Disease and Cancer (Dual Targets)

  Discovery of A New Drug for The Treatment of Alzheimer’s Disease and Cancer - Dr. Rakesh Srivastava WILMINGTON, DE, UNITED STATES, May 26, 2022 /⁨EINPresswire.com⁩/ -- Dr. Rakesh K. Srivastava (President and CEO of GLAX Health) and his international …

  Distribution channels: Business & Economy, Chemical Industry ...